BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8155820)

  • 1. Effects of the peroxisome proliferator perfluoro-n-decanoic acid on hepatic gluconeogenesis and glycogenesis: a 13C NMR investigation.
    Goecke CM; Jarnot BM; Reo NV
    Chem Res Toxicol; 1994; 7(1):15-22. PubMed ID: 8155820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the peroxisome proliferator perfluoro-n-decanoic acid on glucose transport in the isolated perfused rat liver.
    Goecke-Flora CM; Wyman JF; Jarnot BM; Reo NV
    Chem Res Toxicol; 1995; 8(1):77-81. PubMed ID: 7703370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of perfluoro-n-octanoic acid, perfluoro-n-decanoic acid, and clofibrate on hepatic phosphorus metabolism in rats and guinea pigs in vivo.
    Reo NV; Goecke CM; Narayanan L; Jarnot BM
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):165-73. PubMed ID: 8122261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats.
    Kim SC; Hong JT; Jang SJ; Kang WS; Yoo HS; Yun YP
    J Toxicol Sci; 1998 May; 23(2):113-9. PubMed ID: 9644651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of long-chain acyl-CoA synthetase by the peroxisome proliferator perfluorodecanoic acid in rat hepatocytes.
    Vanden Heuvel JP; Kuslikis BI; Shrago E; Peterson RE
    Biochem Pharmacol; 1991 Jul; 42(2):295-302. PubMed ID: 1859447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
    Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
    Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of hepatic acyl-CoA-binding protein and liver fatty acid-binding protein by perfluorodecanoic acid in rats. Lack of correlation with hepatic long-chain acyl-CoA levels.
    Sterchele PF; Vanden Heuvel JP; Davis JW; Shrago E; Knudsen J; Peterson RE
    Biochem Pharmacol; 1994 Aug; 48(5):955-66. PubMed ID: 8093108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative toxicological investigation of perfluorocarboxylic acids in rats by fluorine-19 NMR spectroscopy.
    Goecke CM; Jarnot BM; Reo NV
    Chem Res Toxicol; 1992; 5(4):512-9. PubMed ID: 1391617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gluconeogenesis in the liver of tumor rats.
    Liu KJ; Henderson TO; Kleps RA; Reyes MC; Nyhus LM
    J Surg Res; 1990 Aug; 49(2):179-85. PubMed ID: 2381208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of hepatic immunoglobulin heavy chain binding protein (BiP/Grp78) following exposure to structurally diverse peroxisome proliferators.
    Witzmann FA; Jarnot BM; Parker DN; Clack JW
    Fundam Appl Toxicol; 1994 Jul; 23(1):1-8. PubMed ID: 7958552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorodecanoic acid noncompetitively inhibits the peroxisomal enzymes enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase.
    Borges T; Glauert HP; Robertson LW
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):8-15. PubMed ID: 8430427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
    Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
    Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators.
    Vanden Heuvel JP; Sterchele PF; Nesbit DJ; Peterson RE
    Biochim Biophys Acta; 1993 Jun; 1177(2):183-90. PubMed ID: 8499488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between gluconeogenesis and phosphoenergetics in rat liver assessed by in vivo 13C and 31P NMR spectroscopy.
    Morikawa S; Inubushi T; Takahashi K; Shigemori S; Ishii H
    NMR Biomed; 1997 Jan; 10(1):18-24. PubMed ID: 9251111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of hepatic malic enzyme by perfluorodecanoic acid.
    Kelling CK; Van Rafelghem MJ; Drake RL; Menahan LA; Peterson RE
    J Biochem Toxicol; 1986 Sep; 1(3):23-37. PubMed ID: 3271879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of perfluorodecanoic acid on hepatic stearoyl-coenzyme A desaturase and mixed function oxidase activities in rats.
    Van Rafelghem MJ; Andersen ME
    Fundam Appl Toxicol; 1988 Oct; 11(3):503-10. PubMed ID: 2906022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fate of alanine in an insect Manduca sexta: effects of starvation and parasitism.
    Thompson SN; Lee RW
    Biochim Biophys Acta; 1993 Jul; 1157(3):259-69. PubMed ID: 8100713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peroxisome proliferators on rat liver phospholipids: sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid.
    Adinehzadeh M; Reo NV
    Chem Res Toxicol; 1998 May; 11(5):428-40. PubMed ID: 9585473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator perfluorodecanoic acid alters glutathione and related enzymes.
    Chen LC; Tatum V; Glauert HP; Chow CK
    J Biochem Mol Toxicol; 2001; 15(2):107-13. PubMed ID: 11284052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic gluconeogenesis from alanine: 13C nuclear magnetic resonance methodology for in vivo studies.
    Stromski ME; Arias-Mendoza F; Alger JR; Shulman RG
    Magn Reson Med; 1986 Feb; 3(1):24-32. PubMed ID: 3959887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.